Back to search

United States· US:58657-500_4e6980b2-573c-2636-e063-6294a90ac0f4

Codeine-Guaifenesin

A medicinal product containing codeine phosphate; guaifenesin, registered in United States by Method Pharmaceuticals, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCodeine-GuaifenesinATC—REGISTER NO.US:58657-500_4e6980b2…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CODEINE PHOSPHATE; GUAIFENESIN
Manufacturer
Method Pharmaceuticals, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    58657-500-16
  • ndc11
    5865750004
    120 mL in 1 BOTTLE (58657-500-04)
  • ndc11
    5865750016
    473 mL in 1 BOTTLE (58657-500-16)
  • ndc11
    58657-500-04

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Codeine phosphate; guaifenesin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All codeine phosphate; guaifenesin products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Austria · Resyl Mit Codein
  • Finland · Recipect

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bb1b1d76-ecbf-451b-b375-297fa8cce524
GET /v1/drugs/bb1b1d76-ecbf-451b-b375-297fa8cce524?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10; 100",
  "substance": "CODEINE PHOSPHATE; GUAIFENESIN",
  "productndc": "58657-500",
  "dosage_form": "SOLUTION",
  "dea_schedule": "CV",
  "strength_unit": "mg/5mL; mg/5mL",
  "application_number": "M012",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about codeine phosphate; guaifenesin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.